← Back to Drugs A–Z

Diazepam (Valium)

Group: Depressants
Nicknames: Vallies, Blues, Yellows, V, Valley Girls, MSJ
Last reviewed: October 2026

History

Diazepam was invented by chemist Leo Sternbach in the 1950s, and marketed as Valium in 1963 by Hoffman La-Roche. By 1974, Valium became the most prescribed medication in the United States.

Benzodiazepines were popularised during the post-WWII period, a time of heightened global anxiety in the US and globally (BRP, 2022). Valium adverts from the 1960s and 70s were often targeted towards women, hence the nickname ‘Mother’s Little Helper’. These advertisements often depicted disgruntled housewives in need of ‘fixing’ through benzos.

Consumption and dependence emerged among prominent women including First Lady Betty Ford, triggering a ‘Valium Panic’ across mainstream media. Unlike many other anti-drug moral panics of the time, the Valium Panic was considered “quintessentially middle-class”; exceptionalising women and other people dependent on diazepam as distinct from more marginalised communities who use drugs (Herzberg, 2008).

The Valium Panic led to diazepam and other benzodiazepines becoming controlled substances in the UK under the Misuse of Drugs Act 1971; in the US under the Controlled Substances Act in 1975, and internationally in 1984 under the UN Convention of Psychotropic Substances.

At the turn of the 21st century, as diazepam prescribing in the UK declined, an unregulated market arose. Initially supplying people with diverted prescription benzos, further crackdowns on diazepam supply brought “street Valium” pills into circulation: pills made without regulatory oversight, often containing novel benzos and/or other drugs with limited clinical safety data. These street benzos – especially those containing etizolam or bromazolam – have been key contributors to benzo-related deaths in Scotland, which peaked during the 2020 COVID-19 pandemic. Subsequent restrictions on novel benzos appearing in the counterfeit supply have been followed by a conveyor belt of new benzos and mixtures being sold as diazepam on the unregulated market in the UK and globally. In 2022, several young people across the UK reported taking non-prescribed diazepam and other benzos to self-medicate for anxiety and other unmet mental health needs.

Keep This Information Independent

Release is a registered charity. We rely on your support to provide expert, non-judgmental legal and harm reduction guidance to thousands of people every year.

Donate to Release